NIH-funded research R01 grant

Cell-free RNA signature to diagnose Kawasaki disease and guide personalized treatment in kids

Official title: Cell-free RNA signature for Diagnosis and Personalized Therapeutics in Children with Kawasaki Disease

Funded at University of California, San Diego · NIH-11294040 · Data updated 2026-11-12

A new blood test using tiny fragments of RNA found in the blood is being studied to help diagnose Kawasaki disease in children and tailor treatments to prevent heart complications.

More Kawasaki Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 15, 2026
Project endJune 30, 2028
Funding year2026
Award (this year)$1,639,166
NIH project number1R01HL179031-01A1
Project IDNIH-11294040 on NIH RePORTER

Who could benefit from this research

Could help

Children with suspected Kawasaki disease or at risk for KD-related heart complications, particularly in the 0-11 year age range.

Less likely to help

Children without KD or who do not meet diagnostic criteria may not benefit from this test.

What this research studies

This project will examine cell-free RNA in plasma from children with suspected Kawasaki disease to identify molecular signatures that distinguish KD from other illnesses. Researchers will combine clinical data from UCSD with advanced bioinformatics and RNA analysis from Cornell and Yale to develop a diagnostic biomarker panel. The goal is to enable earlier, more accurate diagnosis and to forecast risk of coronary artery aneurysms and IVIG treatment resistance, paving the way for personalized therapy. The study will involve collecting samples during acute and subacute phases and applying sequencing and computational methods to determine the cell origins of the RNA signals.

Why it matters

Potential benefit: If successful, this work could lead to a rapid, blood-based test that improves diagnosis and helps doctors choose the best initial and adjunctive treatments to protect heart health in children.

How similar studies have gone: Previous work on cfRNA in other diseases suggests cfRNA can reveal tissue-specific information, but this exact KD-focused approach is novel.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Burns, Jane C — University of California, San Diego
  • Study coordinator: Burns, Jane C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.